Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Pacira BioSciences, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
PCRX
Nasdaq
2834
www.pacira.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Pacira BioSciences, Inc.
Pacira BioSciences (PCRX) Could Be 35% Undervalued On Phase 1 Gene Therapy Progress
- Aug 6th, 2026 3:14 pm
Pacira BioSciences Announces Publication of Positive Two-Year Phase 1 Data For PCRX-201 in Annals of the Rheumatic Diseases
- Aug 6th, 2026 6:00 am
Pacira Q2 Earnings & Revenues Beat, 2026 Sales Outlook Cut
- Aug 5th, 2026 10:16 am
Pacira BioSciences Inc (PCRX) (Q2 2026) Earnings Call Highlights: Revenue Growth and Strategic ...
- Aug 4th, 2026 11:05 pm
Pacira BioSciences Q2 Earnings Call Highlights
- Aug 4th, 2026 8:03 pm
Pacira (PCRX) Tops Q2 Earnings and Revenue Estimates
- Aug 4th, 2026 3:40 pm
Pacira BioSciences Reports Second Quarter 2026 Financial Results
- Aug 4th, 2026 2:01 pm
Pacira BioSciences Announces New National Survey Revealing the Hidden Toll of Pain on America’s Workforce
- Jul 28th, 2026 6:00 am
Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing Process
- Jul 27th, 2026 6:00 am
Pacira to Report Second Quarter 2026 Financial Results on Tuesday August 4, 2026
- Jul 22nd, 2026 6:00 am
MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth
- Jul 21st, 2026 7:00 am
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Jul 8th, 2026 6:00 am
PCRX's Exparel Wins Separate Reimbursement From UnitedHealthcare
- Jul 2nd, 2026 7:32 am
Zimmer Biomet (ZBH) Is Buying Pacira’s Iovera Device And Expanding Into Spasticity
- Jul 1st, 2026 10:29 pm
Pacira BioSciences Announces UnitedHealthcare Now Provides Separate Reimbursement for EXPAREL®
- Jul 1st, 2026 6:00 am
Zimmer Biomet to acquire iovera device from Pacira for $140m
- Jul 1st, 2026 4:53 am
Update: S&P 500, Nasdaq Composite Close Strongest Quarter in Six Years Amid Gains in Technology, Decline in Crude Oil
- Jun 30th, 2026 2:56 pm
Sector Update: Healthcare Stocks Softer Late Afternoon
- Jun 30th, 2026 1:41 pm
Top Midday Decliners
- Jun 30th, 2026 12:41 pm
Update: US Equity Indexes Rise as Semiconductors Lift Technology; Crude Oil Slips as Trump's Envoys in Qatar for Indirect Talks
- Jun 30th, 2026 11:42 am
Scroll